Deep-learning allosteric-site prediction identifies celestolide as Botrytis CYP51 inhibitor
Source check: Needs source check. Not independent scientific confirmation.
Finding: Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model. IC50 is weak in absolute terms; abstract only; field efficacy untested.
Technology: Neural relational inference and CorrSite2.0 (Gaussian network deep learning model)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Models identified the allosteric site used to select celestolide.
- Test and result
- Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model.
- Limitation / still unknown
- IC50 is weak in absolute terms; abstract only; field efficacy untested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:%2210.1021/acs.jafc.5c05257%22&resultType=core&format=json
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 17 Nov 2026. Review scope: Abstract and metadata via Europe PMC; full text not read.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.